KSKseniya S. Savchuk

Kseniya S. Savchuk

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kseniya S. Savchuk has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • The relationship between IL-8 levels and cognitive impairment in patients with polymorbidity

    by L.V. Ryabova, K.S. Savchuk, E.P. Shishmintseva

    In recent years, there has been an increase in polymorbidity in therapeutic practice. The clinical symptoms of polymorbidity are quite diverse and nonspecific. Depletion of the neuroimmunoendocrine systems is one of the factors contributing to the development of polymorbidity. The aim of the study was to evaluate the relationship between interleukin-8 levels and cognitive impairment in patients with polymorbidity. Patients complaining of memory impairment were selected after the second stage of an in-depth medical examination of citizens who had recovered from the novel coronavirus infection COVID-19. Inclusion criteria were the presence of three chronic diseases simultaneously in one patient (post-COVID syndrome, type 2 diabetes mellitus, hypertension); signed informed voluntary consent. Exclusion criteria: a history of acute cerebrovascular and coronary circulatory disorders; lymphoproliferative diseases; malignant neoplasms. The study included 22 patients with polymorbidity, including 14 women and 8 men, with an average age of 62.09±8.96 years. Using the multiplex assessment method, the concentration of interleukin-8 in the blood serum was determined to be 8.35 (5.50; 9.33) pg/ml. An analysis of correlation relationships was performed to assess the influence of interleukin-8 concentration on the clinical picture of polymorbidity. Based on the analysis results, a positive correlation was established between the concentration of interleukin-8 and complaints of memory impairment (r=0.663; p=0.002). According to the literature, an increase in the concentration of interleukin-8 was observed in neurodegenerative diseases such as Alzheimer’s disease and vascular dementia. It was shown that cytokines can modulate the function of neurons and glial cells, contributing to neurodegeneration. The data obtained in our study support the role of interleukin-8 in cognitive-related neuroinflammation in polymorbidity.

  • Open Access

    Disturbances in Carbohydrate Metabolism as a Predictor of Decreased Quality of Life in Patients with Post-COVID Syndrome

    by Saint Petersburg Pasteur Institute, K.S. Savchuk, Russian Federation Saint Petersburg, Russian Federation City Clinical Polyclinic No.8; Chelyabinsk, A.S. Simbirtsev, L.V. Ryabova

    Aim. To characterize the quality of life of patients with post-COVID syndrome depending on the presence of newly identified carbohydrate metabolism disorders (CMD) in the post-COVID period. Design. Cross-sectional study. Materials and methods. A total of 132 people with post-COVID syndrome were examined. The patients were divided into two groups: group 1 included 72 people with newly diagnosed impaired glucose tolerance (IGT) (n = 36) and type 2 diabetes mellitus (DM) (n = 36) in the post-COVID period, and group 2 included 60 people without concomitant CMD. The groups were comparable in terms of age and gender. The average age of patients in group 1 was 61.0 [53.3; 66.5] years (with IGT — 58.5 [54.2; 62.5] years, with DM — 63.5 [51.0; 68.3] years), there were 26 men (36.1%), 46 women (63.9%); the average age of group 2 was 56.5 [51.0; 66.0] years, men — 24 (40.0%), women — 36 (60.0%). The duration of the course of post-COVID syndrome at the time of inclusion in the study in patients with IGT was 6.0 [4.8; 6.0] months, with type 2 diabetes — 6.0 [5.0; 6.0] months. The presence of post-COVID syndrome was established on the basis of signs and symptoms that developed during and / or after COVID-19 infection, lasted more than 12 weeks and were not explained by an alternative diagnosis. The diagnosis of CMD (type 2 diabetes and IGT) was established in accordance with the Algorithms for specialized medical care for patients with diabetes mellitus (2021). The quality of life of patients was determined by conducting a questionnaire using the SF-36 questionnaire, containing 8 assessment scales: physical functioning, role physical functioning, vital activity, general health, mental health, social functioning, role emotional functioning, pain intensity, which form two parameters — psychological and physical components of health. The indicators of each scale vary from 0 to 100 points, and a higher result corresponds to a better quality of life of the subject. Patients filled out the questionnaire themselves, the analysis of the results was carried out using a specially developed computer program. Results. The study groups were characterized by polymorbidity, in the 1st group, dyslipidemia (61.1%) and diseases of the urinary system (33.3%) were significantly more common. Patients with CMD had statistically significantly lower quality of life indicators according to the physical and role functioning scales, amounting to 55.00 and 25.00%, respectively. IGT and type 2 diabetes mellitus, first identified in individuals with post-COVID syndrome, had the most significant impact on the assessment of the physical component of health (33.29%), the indicator of the psychological component of health (52.36%) was comparable to that in the group without CMD (54.12%). Conclusion. The combination of post-COVID syndrome and CMD significantly reduces a number of quality of life indicators in this category of patients. One of the significant predictors of deterioration in quality of life in individuals with post-COVID syndrome according to the physical and role functioning scales is CMD identified for the first time in the post-COVID period. Keywords: diabetes mellitus, impaired glucose tolerance, quality of life, SF-36 questionnaire, patients with post-COVID syndrome

  • Open Access

    Genetic basis of metabolic syndrome

    by Liana V. Riabova, Ksenia S. Savchuk

    Metabolic syndrome is a common heterogeneous condition representing a combination of metabolic abnormalities that increase the risk of cardiovascular disease, type 2 diabetes, and other conditions. Over the past decade, studies of the pathogenesis of metabolic syndrome have advanced through the development of molecular genetics, transcriptomics, and sequencing technologies. Numerous studies have demonstrated that the analysis of genetic markers and epigenetic changes associated with metabolic disorders and chronic inflammation is an important area in exploring the pathogenesis and etiology of this condition. The purpose of this review was to describe chromosomal loci and gene polymorphisms associated with metabolic syndrome based on recent Russian and international data published over the last 10 years. Chromosomal loci and gene polymorphisms were assessed in accordance with the main components of metabolic syndrome: insulin resistance, atherogenic dyslipidemia, central obesity, and hypertension. Chromosomal loci specific to patients with manifestations of metabolic syndrome have been identified; however, no single etiologically significant locus has been established to date. The significance of apolipoprotein A5 and E2 gene polymorphisms in the development of metabolic syndrome has been confirmed. The association between FTO gene polymorphism and obesity has been validated. The GCKR gene is associated with elevated triglyceride levels and contributes to the development of obesity and insulin resistance. The BUD13 rs7118999 polymorphism increases the risk of metabolic syndrome. The IL-6 gene polymorphism is associated not only with metabolic syndrome but also with coronary heart disease and type 2 diabetes. The TCF7L2 gene polymorphism is associated with an increased risk of hypertension and low high-density lipoprotein cholesterol levels. The polymorphisms of adiponectin and leptin genes have also been linked to various components of metabolic syndrome. Thus, the findings of studies on gene polymorphisms indicate that most of these genetic variants are involved in lipid metabolism, and a common genetic basis for metabolic syndrome has not yet been established.

  • Impact of comorbid pathology on the cytokine cascade in the population of a large industrial city (using Chelyabinsk as an example)

    by Andrey S. Simbirtsev, Liana V. Ryabova, Kseniya S. Savchuk, Симбирцев Андрей Семенович

    BACKGROUND: The steady increase in the number of patients with comorbid pathology in large industrial cities necessitates the study of the immune response in this category of patients. AIM: To investigate the cytokine profile of residents of a large industrial city (using Chelyabinsk as an example) depending on the presence of comorbid pathology (type 2 diabetes mellitus, obesity, hypertension). MATERIALS AND METHODS: The cross-sectional study included 61 people, including 39 people with type 2 diabetes mellitus and 22 clinically healthy volunteers. The multiplex assessment method was used to evaluate the concentrations of 11 cytokines in the blood serum: GM-CSF, IFN-γ, IL-2, IL-4, IL-5, IL-8, IL-12p70, IL-13, IL-17A, MIP-1β, TNF-α (pg/ml). RESULTS: Determination of the concentration of cytokines in the blood serum of patients with comorbid pathology in Chelyabinsk revealed a number of features, consisting in the predominance of proinflammatory cytokines and chemokines (IFN-γ, TNF-α, IL-8, MIP-1β, IL-12p70, IL-17A) and a shift in the Th1/Th2 balance towards the proinflammatory phenotype Th1. CONCLUSIONS: The obtained results confirm the presence of inflammation in comorbid pathology (type 2 diabetes mellitus, obesity, hypertension) in the population of Chelyabinsk.

  • Open Access

    Distribution of the T cell element of the immune system in post-COVID patients with first identified hyperglycemia

    by K. S. Savchuk, L. V. Ryabova

    Post-COVID syndrome combines many adverse outcomes with often new-onset conditions, including type 2 diabetes mellitus (DM). The relevance of the study is the insufficient data on T cell immunity in patients with hyperglycemia after COVID-19. The purpose of this study was to identify the characteristics of T cell immunity in individuals with post-COVID syndrome and newly diagnosed carbohydrate metabolism disorders (CDM) in the post-COVID period. The study included 100 patients (32 men and 68 women) aged from 38 to 70 years (mean age (M±m) was 59.40±8.80 years) with a verified post-COVID-19 condition. All patients were divided into three groups: group 1 – patients with concomitant newly diagnosed impaired glucose tolerance (IGT) in the post-COVID period (prior to SARS-CoV-2 infection, no increase in glycemia was detected according to primary medical documentation) (n = 30), group 2 – patients with concomitant newly diagnosed type 2 diabetes mellitus (n = 30), and group 3 – patients with the development of post-COVID syndrome without hyperglycemia (n = 40). During the study, the following parameters were determined: CD45+, CD3+ (T lymphocytes), CD45+, CD3+, CD4+ (helper inducers), CD45+, CD3+, CD8+ (cytotoxic T lymphocytes), CD45+, CD3+, CD4+, CD25+, CD127- (T regulatory cells), CD45+, CD3+, CD4+, CD25+ (T lymphocytes – early activation), CD45+, CD3+, HLA-DR+ (T lymphocytes – late activation). Infection with SARS-CoV-2 with the subsequent development of post-COVID syndrome and persistent hyperglycemia (IGT, type 2 diabetes) in the post-COVID period was accompanied by a higher level of the total number of T lymphocytes. A study of the T lymphocyte population revealed changes in the subpopulation composition. In the group of patients with CDM, a significant increase in T cytotoxic and T regulatory cells was noted. More pronounced changes in the subpopulation composition were identified in the group of patients with newly diagnosed type 2 diabetes in the post-COVID period: an increase in the relative and absolute numbers of T helper cells and T cells of late activation of lymphocytes. Disorders of carbohydrate metabolism associated with COVID-19 are accompanied by changes in the subpopulation composition of T lymphocytes. In individuals with newly diagnosed type 2 diabetes in the post-COVID period, hyperactivation of the T cell component of the immune system was revealed. Heterogeneous data were obtained in individuals with newly diagnosed impaired glucose tolerance, which requires further study of this group of patients.

  • Clinical features of post-COVID syndrome in patients with carbohydrate metabolism disorders

    by Ksenia S. Savchuk

    Objective: clinical characteristics of patients with carbohydrate metabolism disorders (CDM) in the post-COVID period. Material and methods. 72 people with CDM in the post-COVID period were examined. Results. When detailing complaints, the incidence of respiratory symptoms in patients with impaired glucose tolerance (IGT) and diabetes mellitus (DM) was comparable. In both groups, nonspecific (general weakness) and neurological (memory deterioration, sleep disturbances, decreased vital activity) symptoms predominated. The development of NUD in the post-COVID period was facilitated by such risk factors as age >45 years, body mass index >25 kg/m2, family history of type 2 diabetes, hypertension. The most common concomitant diseases were overweight and obesity — in 64 (88.9%) patients, dyslipidemia — in 44 (61.1%), hypertension — in 32 (44.4%). In the group of patients with IGT, the frequency of re-infection with SARS-CoV-2 was higher compared to the group of patients with diabetes, and there was a tendency for the course to become more severe with re-infection. Conclusion. In the post-COVID period, patients with IGT and diabetes are more likely to have nonspecific and neurological complaints, while identified NDEs can aggravate the course of concomitant diseases and lead to re-infection with SARS-CoV-2.

  • The effect of post-covid syndrome on the cytokine cascade in patients with type 2 diabetes mellitus

    by Kseniya S. Savchuk, Andrey S. Simbirtsev, Liana V. Ryabova, Симбирцев Андрей Семенович

    With the increasing prevalence of type 2 diabetes, it is of interest to study the characteristics of the immunological status in this category of patients. According to modern data, in type 2 diabetes, a pro-inflammatory type of immune response is formed with an imbalance between T-helper 1 (Th1), T-helper 2 (Th2), T-helper 17 (Th17) types and T-regulatory cells (Treg). The COVID-19 pandemic makes a certain contribution to changes in the immune response in patients with type 2 diabetes mellitus, since in patients who have had coronavirus infection, significant changes in the composition of circulating immune cells are observed: the proportion of Th17 increases and the number of Tregs decreases. This study is devoted to identifying the features of the cytokine cascade in patients with type 2 diabetes mellitus, depending on the presence of a confirmed history of SARS-CoV-2 infection. The study included 75 patients with type 2 diabetes, in 36 of them the diagnosis was verified in the post-Covid period. The study was conducted at least 6 months after pneumonia caused by SARS-CoV-2 infection. All study participants signed informed consent. The study was approved by the Independent Local Ethics Committee at the State Autonomous Institution of Regional Clinical Hospital “City Clinical Hospital No. 1” of Chelyabinsk, protocol No. 8 dated 04/11/2022, on the basis of which these studies were conducted. Using the multiplex assessment method, the concentrations of 15 cytokines in the blood serum were assessed in patients: GM-CSF, IFNγ, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12 (p70), IL-13, IL-17A, MIP-1β, TNFα. The results obtained during the study showed not only a change in the number of cytokines, but also a change in the balance of pro- and anti-inflammatory cytokines, cytokines that regulate forms of development of acquired immunity, in the group of patients with type 2 diabetes in the post-Covid period. In the post-Covid period, in patients with type 2 diabetes mellitus, the concentrations of cytokines secreted by Th1, Th2, Th17 cells, and Tregs sharply decreased. It has been determined that patients with type 2 diabetes mellitus after SARS-CoV-2 infection develop a functionally inferior virus-specific T-cell response, characterized by reduced or suppressed secretion of the cytokines GM-CSF, IFNγ, IL-1β, IL-2, IL -4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12 (p70), IL-13, IL-17A, MIP-1β, TNFα. A weak T-cell response may increase the likelihood of developing pathological processes associated with an inadequate response to viral antigens (including repeated infections with the SARSCoV-2 virus, exacerbation of chronic infections).


  • Open Access

    Characteristics of T-cell immunity and level of the natural killer cells content in COVID-19 convalescents with carbohydrate metabolism disorders

    by K. S. Savchuk

    The pandemic of the new COVID-19 coronavirus infection has created a public health emergency in the Russian Federation in 2020-2022. COVID-19 causes various consequences, often manifested by the endocrine system dysfunction. The rationale for our study is insufficient data on T and NK cell immunity in patients with hyperglycemia after COVID-19. The study was aimed at the features of T cell immunity in individuals with post-COVID syndrome and disorders of carbohydrate metabolism, depending on the NK cells count. Materials and methods: Sixty-four post-COVID patients with carbohydrate metabolism disorders were divided into three groups: with reduced, normal, or elevated NK cell counts. Carbohydrate metabolism disorders included impaired glucose tolerance (n = 36) and type 2 diabetes mellitus (n = 28). The comparison group comprised 60 post-COVID persons with no history of carbohydrate metabolism disorders. The assessment of the lymphocytic link of immunity included the definition of: CD45+CD3+ (T lymphocytes), CD45+CD3+CD4+ (T helpers), CD45+CD3+CD8+ (T cytotoxic), CD45+CD3+CD16+CD56+ (T-NK cells), CD45+CD3-CD16+CD56+ (natural killers), CD45+CD3+CD4+CD25+ (T lymphocytes – early activation), CD45+CD3+HLA-DR+ (T lymphocytes – late activation). Results and Discussion. As the study showed, a decrease in the number of natural killers was accompanied by a higher level of T helpers in the group with carbohydrate metabolism disorders, the latter is probably associated with a compensatory increase in T lymphocytes and dysregulation of the T cell link of the immune system. It can also be concluded that in patients with long-COVID and CMD, with normal NK cell counts, an altered subpopulation composition remains, namely, a significant increase in total T lymphocytes. Many authors associate the obtained data on a significant decrease in T-NK lymphocytes with a decrease in the antiviral activity of the immune system, which can lead to a poor response to new viral agents or contribute to the activation of chronic viral infections. Dysregulation of the T cell link in individuals with long-COVID and disorders of carbohydrate metabolism requires a more detailed study, including an assessment of the cytokine profile in this category of patients.


  • The state of functional activity of neutrophils in patients with various variants of carbohydrate metabolism disorders who have had SARS-COV-2S infection

    by Ksenia S. Savchuk, Center For Obstetrics And Gynecology No. 1, Liana V. Ryabova, Federal State Budgetary Educational Institution of Higher Education «South Ural State Medical University» of the Ministry of Health of the Russian Federation

    According to the Federal State Statistics Service of the Russian Federation, there has been a significant increase in the prevalence of prediabetes and type 2 diabetes mellitus (DM). Type 2 diabetes is characterized by frequent disability due to the progression of complications of diabetes and high mortality. Domestic and foreign authors have shown that neutrophils play an important role in the development of diabetic micro- and macroangiopathies. It has been shown that in DM, changes in the functional activity of neutrophils are observed, manifested in a decrease in chemotactic activity, changes in phagocytic activity, leukotriene production, and secretion of lysosomal enzymes. According to the results of previous studies, ambiguous data were obtained on the effect of high hyperglycemia in DM on the phagocytic activity of neutrophils. Thus, foreign authors have shown that in DM, when the target levels of glycemic control are not reached, the phagocytic activity of neutrophils is inhibited. Other researchers have found that with DM, activation of the phagocytic function of neutrophils is detected, but at the same time, the reaction of neutrophils to additional stimulation with latex (according to the results of the HCT test), a decrease in the expression of adhesion molecules on their surface and the ability to form extracellular traps occurs. Neutrophils, being the main cells of innate immunity, play an important role in the antiviral response. Patients with impaired carbohydrate metabolism are at high risk of severe course and unfavorable outcome of SARS-CoV-2 infection. The course and outcome of an infectious disease depends on how the effector functions of neutrophils are realized. The aim of the study was to study the features of the functional activity of neutrophils in patients with various variants of carbohydrate metabolism disorders who had SARS-CoV-2 infection. The study included 20 patients with impaired carbohydrate metabolism who had suffered SARS-CoV-2 infection, the control group included 15 clinically healthy volunteers. In all groups, the phagocytic activity of latex particles with a diameter of 1.7 microns was evaluated by neutrophils (phagocytosis activity, phagocytosis intensity, phagocytic number); spontaneous and induced NBT activity of neutrophils by morphological method. A significant increase in the absorption capacity of peripheral blood neutrophils, an increase in the phagocytic activity of leukocytes in the group of patients with impaired carbohydrate metabolism was revealed. A simultaneous increase in the indicators of spontaneous and induced HCT tests was found in the group of patients with impaired glucose tolerance and in the group of patients with type 2 diabetes mellitus. The observed disorders in the phagocytic link are an important factor in reducing the overall immunoreactivity of patients, which determines the long rehabilitation period. Identifying the features of innate immunity in patients with various variants of carbohydrate metabolism disorders who have suffered from SARS-CoV-2 infection will further help develop an individual strategy for the prevention and treatment of these diseases.